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Abstract 
Background: Smoking has been associated with several types of mental illness namely schizophrenia, depression, 
bipolar disorders with a prevalence of smoking twice that of the general population. The study objective was to 
ascertain whether waterpipe tobacco smoking (WTS), cigarette smoking and all types of tobacco smoking are more 
common among Bahraini patients with severe and persistent mental illness (SPMI) than the general population.
Methods: A cross-sectional study was conducted on 222 adult SPMI both in- and out- patients who attended the 
Psychiatric Hospital in Bahrain. A 29-item questionnaire, which included sociodemographic variables, pattern and his-
tory of psychiatric illness and a comprehensive smoking history, was used. Comparative smoking data were obtained 
from the Bahraini National Non-communicable Diseases Risk Factors Survey.
Results: The prevalence of smoking of tobacco among SPMI patients was 30.2 % compared to 19.9 % in the general 
population. The corresponding values for cigarette smoking were 25.2, 13.8 %, respectively and for WTS, 11.3, 8.4 %, 
respectively. SPMI patients were 1.7 (95 % CI 1.3, 2.4 %) times more likely to be smokers, 2.1 (95 % CI 1.5, 2.9 %) times, 
cigarette smokers and 1.4 (95 % CI 0.9, 1.9 %) times WTS than the general population. SPMI patients smoked at a 
younger age and consumed more cigarettes than the general population. The mean age started smoking was lower 
among men than women, similar for cigarettes, and higher for WTS.
Conclusions: The prevalence of smoking among patients with SPMI in Bahrain is twice that of the general popula-
tion. The findings of the study have implications on the provision of healthcare to mentally ill patients in the country.
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Background
Smoking is a major determinant of global health. In 2013, 
it occupied the second rank among the global risk fac-
tors, accounted for 6.1 million deaths and 143.5 million 
DALYs [1, 2]. It is a major risk factor for several non-
communicable and respiratory diseases and substantially 
affects the health of fetuses of pregnant women and chil-
dren exposed to tobacco smoke [3]. Most of the evidence 
of the effects of smoking is based on cigarette smoking, 
however the health effects of waterpipe tobacco smoking 
(WTS) became evident in recent years [4, 5].
Although the smoking prevalence has decreased over 
the past few decades in the general population in most 
countries, it remains a public health priority as the num-
ber of smokers increased significantly as a result of popu-
lation growth and disproportionately high for distinct 
groups such as those with severe mental illness [1, 6–8].
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Smoking has been associated with several types of 
mental illness namely schizophrenia, depression, anxi-
ety disorders, bipolar disorders and dementia. The 
prevalence of smoking among those with mental illness 
is twice that of the general population [7, 9]. Moreover, 
patients with coronary heart disease were reported to 
have high levels of depression highlighting the impor-
tance of tobacco control in mental illness [10]. Primack 
and colleagues reported that the associations of mental 
health problems were stronger for cigarette smoking than 
WTS [11]. In the United States (US), nearly 1 in 5 adults 
have some form of mental illness, of whom 36 % smoke 
cigarettes. In comparison, 21  % of US adults without 
mental illness smoke cigarettes [12]. Notably, the rate of 
tobacco use increases three times in the psychiatric pop-
ulation, and in particular, a range of 40–100  % is found 
among schizophrenics. Up to 90 % of those with schizo-
phrenia smoke cigarettes [13, 14]. Accordingly, smokers 
with schizophrenia are 30 % more likely than smokers in 
the general population to die from cardiovascular dis-
ease and 60 % more likely to die from respiratory disease 
[15, 16]. The average life expectancy for individuals with 
schizophrenia is 20 % lower than the general population 
[17]. Schizophrenic patients may perceive the health risks 
of cigarette smoking to be less than the normal popula-
tion [18]. Adults with mental illness smoke 70 % of con-
sumed cigarettes in the US [19]. 40 % of men and 34 % 
of women with mental illness smoke. Additionally, 48 % 
of people with mental illness who live below the poverty 
level smoke, compared with 33 % of those with mental ill-
ness who live above the poverty level [12].
Tobacco smoking has attracted the attention of mental 
health professionals worldwide in recent years. Experts 
attribute the link between smoking and mental illness to 
a number of factors, which include the biochemistry of 
tobacco and nicotine, the nature of mental illnesses and 
the culture of mental health system [9]. However, most 
of the research that explored the association between 
tobacco smoking and mental illness was based on ciga-
rette smoking and not WTS [20].
Little published work has focused on determining the 
prevalence of tobacco smoking among patients with 
mental illnesses in Arab and other Middle Eastern coun-
tries [21, 22] and its comparison to that of the general 
population. An Egyptian study found no difference in 
smoking rate among schizophrenic patients with or with-
out obsessive–compulsive symptoms [22]. A recent study 
from a center in north Iraq reported higher smoking rates 
for schizophrenic patients compared to other mental dis-
orders and that they had smoked earlier than appearance 
of their first symptoms [23]. A research from Saudi Ara-
bia reported a prevalence rate of 57.9 % among the male 
outpatient population compared to 78  % of psychiatric 
inpatient in Iran [21, 24]. The prevalence rates of smok-
ing in Saudi patients with different diagnoses were as 
follows: schizophrenia 56.5 %, major depressive disorder 
(MDD) 59.6  %, anxiety disorders 53.0  % and substance 
abuse 72.0 % [21]. These studies focused on specific psy-
chiatric populations, from limited geographic areas and 
did not include community population or national smok-
ing statistics.
The Bahraini National Non-communicable Diseases 
Risk Factors Survey (NNDRFS) in 2007 reported that the 
prevalence of smoking of all types of tobacco in males, 
females and both sexes combined in Bahraini nationals 
was 33.4, 7.0 and 19.9  %, respectively [25]. The corre-
sponding figures for cigarette smoking were 27.0, 1.2 and 
13.8 %, respectively and that of WTS, 10.8, 6.2 and 8.4 %, 
respectively. No previous studies have been under taken 
in Bahrain to examine the prevalence of smoking among 
patients with mental illness.
The Psychiatric Hospital in Bahrain is the main and 
only public services facility for mental illness in the coun-
try. In 2012, 405 patients were admitted to the Psychiatric 
Hospital in the age group 15–64  years. 232 were diag-
nosed with schizophrenia, 97 bipolar affective disorder 
(BAD) and 77 MDD according to the Ministry of Health’s 
2012 Annual Report [26]. The objective of this study was 
to ascertain whether WTS, cigarette smoking and all 
types of tobacco smoking are more common among Bah-
raini patients with severe and persistent mental illness 
(SPMI) than the general population (NNDRFS).
Methods
A cross sectional study was conducted on adult (20–
64  years) Bahraini outpatients and inpatients who 
attended the Psychiatric Hospital in Bahrain with SPMI 
from 1 November 2014 to 31 January 2015.
The Psychiatric Hospital was founded in 1932. The 
hospital has 246 inpatient beds (16-beds for alcohol and 
drug dependence patients, 55 for acute patients, 40 for 
short-stay patients, 10 for child psychiatry, 80 for long-
stay patients and 45 for the intellectual disabilities). The 
Psychiatric Hospital is considered to be the main center 
for psychiatric care services in the country. The hospital 
works for 24 h and accepts psychiatric disorder and social 
cases which come directly or are referred from other hos-
pitals and health centers.
A convenient sample of 240 SPMI patients, which 
included schizophrenia, BAD and MDD classified 
according to the International Classification of Disease 
(ICD 10) criteria was selected. SPMI patients whose 
mental status did not allow them to be interviewed or 
had comorbidity with other psychiatric diagnoses were 
excluded from the study. Convenience non-probabil-
istic sampling technique was the most applicable and 
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feasible technique in this research due to the nature of the 
research topic. The sample size was determined using the 
prevalence of smoking in Bahrain (19.9 %) based on that 
reported in the NNDRFS, alpha of 0.05 and a beta of 0.80. 
This resulted in a minimum sample size of 210 patients. 
Data collection included all of the general adult psychiat-
ric clinics in the hospital on all working days of the week 
during the 2  months data collection period. Eighteen 
patients refused to participate in the study mostly due to 
transport related matters and 222 accepted.
Two independent, trained hospital staff collected the 
data for this research during a semi-structured interview 
session. These patients were regularly following up their 
treatment appointments with psychiatrists, and had been 
seen on many previous occasions by a multidisciplinary 
team, thus comprehensive data had been recorded in 
their medical record files. These files were reviewed for 
abstracting socio-demographic characteristics, diagno-
sis, and clinical history. In addition, the data collection 
staff interviewed the patients privately and recorded their 
responses using a 29-item questionnaire, which included 
questions on smoking history taken from the NNDRFS. 
The latter used face-to-face interviews similar to the 
data collection method of the current study. Smokers 
were defined according to those used in the NNDRFS to 
allow comparisons. Smoking status was categorized into 
current daily, current occasional, ex- and non-smokers. 
Smokers were classified according to tobacco types as 
cigarette (manufactured and hand-rolled), shisha (water-
pipe) or other types (cigar or pipe) smokers. Average 
number of cigarettes smoked daily was calculated for 
daily smokers only [25].
The researchers briefed each patient as well as key 
relatives regarding this study. Participating patients gave 
their consent prior to interview and those who refused 
were excluded.
Data was entered and analyzed using the SPSS ver-
sion 22.0. Chi-square test, independent samples t test 
and ANOVA were used where applicable. The p value 
was considered significant at <0.05. The standardized 
smoking prevalence ratios (SSPR) were calculated simi-
lar to the method used to calculate standardized mor-
tality ratios. To get the expected number of smokers, 
the age specific smoking rates from each age group in 
the standard population were multiplied by the corre-
sponding number of SPMI in that age group. The total 
expected number of smokers was obtained by summing 
the expected numbers of smokers in each age group. The 
observed total number of smokers among the SPMI was 
divided by the expected number of smokers and then 
multiplied by 100 to get SSPR. This was repeated for all 
types of smoking, cigarettes and WTS. The correspond-
ing 95 % confidence intervals were calculated for SSPR.
Ethical approval was attained from the Research Tech-
nical and Support Committee, Ministry of Health, King-
dom of Bahrain.
Results
Of the 222 SPMI patients (46 inpatients and 176 out-
patients), there were 99 with schizophrenia (44.6 %), 86 
BAD (38.7  %) and 37 (16.7  %) MDD. Table  1 show that 
the majority of the patients were in the age groups 40–49 
and 30–39. The SPMI patients were almost similar with 
respect to gender but there was a significantly lower per-
centage (p = 0.002) of females among schizophrenia, half 
that of MDD. About 40.0  % of SPMI patients had less 
than a high school degree and over half had a monthly 
family income of 150–500 BD (398–1327 US $). Only 
21.2 % of SPMI patients were employed with statistically 
significant (p < 0.0001) differences between the patients 
of the three clinical categories.
Sixty eight percent of SPMI patients were diagnosed for 
over 5 years. The corresponding proportions for schizo-
phrenia, BAD and MDD were 79.8, 55.8, 64.0 %, respec-
tively (p  <  0.0001). The mean outpatient visits during 
2014 of SPMI patients were 6.9 (95  % CI 6.3, 7.5) with 
slight variation between the diagnoses (schizophrenia, 
7.3 (95  % CI 6.2, 8.3), MDD 6.6 (95  % CI 5.7, 7.5) and 
BAD 6.6 (95 % CI 5.1, 8.2). There was a statistically sig-
nificant difference in the number of admissions to the 
Psychiatric Hospital (p < 0.0001) with over one third of 
schizophrenic patients (35.4  %) having over six admis-
sions in the past 5  years compared to 5.8  % of BAD, 
27.0 % MDD and 22.5 % for all SPMI patients.
Almost one third of the SPMI patients were smokers 
(30.2 %, 95 % CI 24.2, 36.7 %). The prevalence of smoking 
was higher in men (47.7  %, 95  % CI 38.1, 57.5  %) com-
pared to 13.3 % for women (Table 2). Cigarette smoking 
(46.8  %, 95  % CI 37.2, 56.6  %) was more popular than 
WTS (11.0 %, 95 % CI 5.8.1, 18.4 %) among men. In con-
trast, WTS (11.5 %, 95 % CI 6.3, 18.9 %) was almost dou-
ble that of cigarette smoking (4.4 %, 95 % CI 1.4, 10.0 %) 
among women. The prevalence of WTS was similar in 
both sexes. The differences among the clinical categories 
with respect to smoking were not significant except for 
cigarette smoking in both genders. In both sexes com-
bined and among men, BAD had the highest prevalence 
of smoking any type of tobacco (35.1 %, 95 % CI 20.2, 52.5 
and 58.8 %, 95 % CI 32.9, 81.6 %, respectively).
SPMI had higher proportions of ever tobacco smokers 
in males (83.5  %), females (3.2  %) and both sexes com-
bined (57.2 %) than those reported in the NNDRFS (48.7, 
1.1, 29.5  %, respectively). The percentages for former 
smokers of any type of tobacco in SPMI males (35.8 %), 
females (18.5  %) and both sexes combined (27.0  %) 
were also higher than in the NNDRFS (15.3, 4.1, 9.6  %, 
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respectively). The prevalence of current smoking of any 
type of tobacco among SPMI patients was 30.2  % com-
pared to 19.9 % in the general population (p = 0.001). The 
corresponding values for cigarette smoking were 25.2 %, 
13.8, respectively (p < 0.0001) and for WTS 11.3, 8.4 %, 
respectively. 62.7  % of smokers among SPMI patients 










No. % No. % No. % No. %
Gender*
 Male 61 61.6 31 36.0 17 45.9 109 49.1
 Female 38 38.4 55 64.0 20 54.1 113 50.9
Age
 20–29 18 18.2 13 15.1 9 24.3 40 18.0
 30–39 27 27.2 14 16.3 9 24.3 50 22.5
 40–49 25 25.3 27 31.4 9 24.3 61 27.5
 50–59 17 17.2 16 18.6 7 18.9 40 18.0
 60–64 12 12.1 16 18.6 3 8.2 31 14.0
Education
 Illiterate 9 9.1 6 7.0 2 5.4 17 7.7
 Read and write 7 7.1 6 7.0 1 2.7 14 6.2
 Primary 12 12.1 7 8.0 4 10.8 23 10.4
 Intermediate 17 17.2 12 14.0 6 16.2 35 15.8
 High school 40 40.4 35 40.7 15 40.5 90 40.5
 University 14 14.1 20 23.3 9 24.4 43 19.4
Income (BD)
 <150 28 28.3 13 15.1 7 18.9 48 21.6
 150–500 45 45.5 50 58.1 19 51.4 114 51.4
 >500 26 26.3 23 26.7 11 29.7 60 27.0
Employment**
 Employed 14 14.2 22 25.6 11 29.7 47 21.2
 Not employed 53 53.5 17 19.8 9 24.3 79 35.6
 Housewife 18 18.1 32 37.2 8 21.6 58 26.1
 Retired 14 14.2 15 17.4 9 24.3 38 17.1
Table 2 Prevalence of smoking of SPMI patients by diagnosis, gender and type
a 95 % CI
Type Schizophrenia MDD BAD Totala p value
Male
 Cigarettes 49.2 (36.1, 62.3) 35.5 (19.2, 54.6) 58.8 (32.9, 81.6) 46.8 (37.2, 56.6) 0.445
 Waterpipe 9.8 (3.7, 20.2) 16.1 (5.5, 33.7) 5.9 (0.1, 28.7) 11.0 (5.8, 18.4) 0.504
 Any type 49.2 (36.1, 62.3) 38.7 (21.9, 57.8) 58.8 (32.9, 81.6) 47.7 (38.1, 57.5) 0.387
Female
 Cigarettes 2.6 (0.1, 13.8) 5.5 (1.1, 1.5) 5.0 (1.3, 24.9) 4.4 (1.4, 10.0) 0.802
 Waterpipe 5.3 (0.6, 17.7) 14.5 (6.5, 26.7) 15.0 (3.2, 37.9) 11.5 (6.3, 18.9) 0.334
 Any type 7.9 (1.7, 21.4) 16.4 (7.8, 28.8) 15.0 (3.2, 37.9) 13.3 (7.6, 20.9) 0.481
Both sexes
 Cigarettes 31.3 (22.4, 41.4) 16.3 (9.2, 25.8) 29.7 (15.9, 47.0) 25.2 (19.7, 31.5) 0.050
 Waterpipe 8.1 (3.6, 15.3) 15.1 (8.3, 24.5) 10.8 (3.0, 25.4) 11.3 (7.4, 16.2) 0.318
 Any type 33.3 (24.2, 43.5) 24.4 (15.8, 34.9) 35.1 (20.2, 52.5) 30.2 (24.2, 36.7) 0.324
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smoked cigarettes only compared to 53.7 % of the popu-
lation, 16.4 % WTS only compared to 26.4, 20.9 % mixed 
compared to 15.9 %. None of the SPMI smokers smoked 
cigar or pipe compared to 4.0 % of the general population.
Male SPMI patients were 1.8 times more likely to be 
smokers and 2.4 times to be cigarette smokers than the 
general population but similar with respect to WTS. 
As for women patients with SPMI, they were 2.0 times 
more likely to be smokers and WTS and 3.8 times to 
be cigarette smokers than the general population. The 
odds ratios for both sexes combined were 1.7, 2.1 and 
1.4, respectively (Table 3). The SSPR for cigarette smok-
ing among SPMI patients was 190 (95 % CI 144, 247 %). 
The corresponding SSPRs for WTS and all type of smok-
ing were 85 (95 % CI 55, 126 %) and 153 (95 % CI 119, 
194  %), respectively. All SPMI patients who smoked 
cigarettes were daily smokers compared to 96.3 % of the 
cigarette smokers in the population. As for WTS, 45.6 % 
were occasional smokers in the population compared to 
none among SPMI patients. Further, a higher percent-
age of SPMI patients were former smokers (27.0 %) than 
the population (9.6  %). The corresponding proportions 
among men were 35.8, 15.3  %, respectively and women 
18.5, 4.1 %, respectively.
The mean age started smoking any tobacco was 
lower among men (15.9  ±  0.5  years) than women 
(18.0 ± 7.3 years), similar for cigarettes (15.9 ± 0.5 and 
16.0 ± 6.4, respectively) but higher for WTS (24.2 ± 8.9 
and 18.8  ±  7.7, respectively (Table  4). The differences 
between the SPMI categories were not statistically signif-
icant. Further, the mean age at starting to smoke among 
SPMI patients was lower than the general population for 
all age groups but the differences were statistically signifi-
cant only for the age group 20–29 years. MDD patients 
started to smoke at a younger age (15.3 ± 5.1) than schiz-
ophrenics (16.2 ± 3.8) and BAD (18.5 ± 5.2). Moreover, 
SPMI patients started cigarette smoking at a younger age 
than the general population in both sexes (Table 5). 
Male, female and both sexes combined of SPMI 
patients consumed higher number of cigarettes daily 
compared to the general population (Table 6). There were 
no statistically significant differences among the SPMI 
categories with respect to tobacco consumption. The 
average number of cigarettes per day was highest among 
schizophrenia patients in men, women and both sexes 
and MDD for WTS per week.
Discussion
One third of SPMI in both sexes combined and half of 
the males were smokers. The number of smokers among 
SPMI was twice that of the general population for all 
types. This finding is consistent with some reported stud-
ies [7, 27, 28]. Such high prevalence of smoking among 
SPMI patients would increase the risk of smoking related 
health complications and death from vascular diseases, 
cancer and other disease conditions [29, 30]. Article 4 
of the Bahrain 2009 Antismoking Law prohibits tobacco 
smoking in closed public places including health estab-
lishments; however the majority of the SPMI in the study 
was outpatients and could smoke freely outside the hos-
pital premises. As for inpatients they generally smoked 
Table 3 Prevalence rates of  smoking by  gender and  type: 







 Cigarettes 46.8 27.1 2.4 (1.6, 3.5)
 Waterpipe 11.0 10.8 1.0 (0.5, 1.9)
 Any type 47.7 33.4 1.8 (1.2, 2.7)
Female
 Cigarettes 4.4 1.2 3.8 (1.3, 11.0)
 Waterpipe 11.5 6.2 2.0 (1.0, 3.7)
 Any type 13.3 7.1 2.0 (1.1, 3.7)
Both sexes
 Cigarettes 25.2 13.8 2.1 (1.5, 2.9)
 Waterpipe 11.2 8.4 1.4 (0.9, 1.9)
 Any type 30.2 19.9 1.7 (1.3, 2.4)
Table 4 Mean age started smoking by tobacco type and mental disorder






Mean SD 95 % CI Mean SD 95 % CI Mean SD 95 % CI
Schizophrenia 16.0 3.8 14.9 17.4 22.3 8.1 15.5 29.0 16.2 3.8 14.9 17.6
MDD 15.0 3.9 12.8 17.2 18.8 9.2 13.3 24.4 15.3 5.1 13.0 17.7
BAD 16.9 3.5 14.5 19.3 27.8 3.2 22.7 32.8 18.5 5.2 15.4 21.7
Total 15.9 3.7 14.9 16.9 21.4 8.5 17.8 24.9 16.4 4.6 15.3 17.5
F 0.804 1.844 2.062
p value 0.453 0.182 0.136
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outside the building but for those who were unable to 
go out (none of the study population were in this cat-
egory) they have an allocated room for them to smoke. 
This raises the question whether the Psychiatric Hospi-
tal should continue to permit smoking for those patients 
irrespective of the law or completely prohibit it [31, 32].
WTS among SPMI patients was 1.5 times that of the 
general population. Comparative data of WTS among 
mentally ill patients in the region is scarce as WTS and 
mental illness was not well researched in the region. It is 
noteworthy that Nejad and Pouga reported similar figures 
of hookah smoking rate among inpatients with SPMI in 
Iran [33]. The finding that cigarette smoking was higher 
in both sexes among SPMI compared to the population 
is expected. Given that SPMI use tobacco more than the 
general population, it is not surprising that SPMI women 
had higher rates of WTS as it is more culturally accept-
able for  women to smoke waterpipe than cigarettes. In 
contrast, any type of tobacco use by men is socially toler-
ated. Further, the higher daily consumption of cigarettes 
by SPMI patients compared to the general population is 
consistent with the literature as these patients tend to use 
cigarettes to alleviate their symptoms [33].
Another important finding was that more than one 
third of male SPMI patients who ever smoked (35.8  %) 
quit smoking compared to 15.3 % from the same gender 
in the general population. This indicates even a higher 
smoking prevalence among this vulnerable population. 
Cigarette smoking was higher among schizophrenia and 
BAD patients compared to those with MDD (p = 0.050). 
SPMI patients may use smoking as a way of self-medica-
tion to alleviate symptoms and improve cognition [33, 
34].
Furthermore, high smoking rates among SPMI patients 
support some theories that try to explain why mentally 
ill patients smoke more than the general population. It 
has been reported that nicotine derivatives interfere with 
the metabolism of some of the antipsychotic medication 
and can affect blood drug levels [35, 36]. It could be that 
psychotic patients smoke in order to reduce the effect 
of these medications and their side effects. The finding 
that SPMI patients smoke at a younger age and consume 
more cigarettes than the general population further sup-
ports studies from other parts of the world [7].
The study had some limitations as the sample included 
patients with long mental illness history and frequent 
hospital admissions, which might make them possibly 
different from SPMI patients in the community. Further, 
the prevalence of smoking in the general population was 
based on those of 2007; the only available data and the 
time lag between NNDRFS and this study cannot be 
overlooked. Finally, the generalizability of the findings is 
limited since convenience sampling in the selection of the 
study population was used.
The major strength of this study is that it is the first of 
its kind in the Eastern Mediterranean Region as it com-
pares mentally ill patients with the general population 
with respect to cigarette smoking, WTS and all types of 
tobacco smoking in both sexes.
The implication of the research results on policy and 
practice at the Psychiatric Hospital include abolishing the 
use of cigarettes as an incentive in long stay wards, intro-
ducing smoking related questions in the personal history 
of patients, adding the subject of smoking to the psycho-
education program of schizophrenic patients and provid-
ing smoking cessation assistance to smokers. Smokers 
can be referred by their psychiatrists to the Quit Tobacco 
Clinics (QTC) as these clinics are available free of charge 
to any smoker intending to quit or has been referred by 
the physician. Further, the Ministry of Health might con-
sider opening a QTC at the Psychiatric hospital as the 
QTC are located in the primary healthcare centers of the 
ministry.
Conclusions
The findings of this study highlight the importance of 
smoking prevention and cessation programmes. All 
efforts should be mobilized to strengthen tobacco control 
measures in the country and modify the hospital poli-
cies and regulations to control tobacco use. Moreover, 
including tobacco use in personal history and providing 
Table 5 Mean age started cigarette smoking of  SPMI 
patients by  gender: comparison with  the general popula-
tion
Number Mean Std. deviation p value
Male
 SPMI 51 30.5 19.7 <0.0001
 NNDRFS 224 19.4 12.5
Female
 SPMI 5 23.0 16.4 0.170
 NNDRFS 11 10.2 7.2
Both sexes
 SPMI 56 29.8 19.5 <0.0001
 NNDRFS 235 18.9 12.5
Table 6 Average number of  cigarettes smoked daily 
by SPMI patients and the general population by gender
Gender SPMI General population p value
Male 30.5.4 ± 19.7 19.4 ± 12.5 <0.0001
Female 23.0 ± 16.4 10.2 ± 7.2 0.170
Both sexes 29.8 ± 19.5 18.9 ± 12.5 <0.0001
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smoking cessation assistance to smokers needs to be seri-
ously considered. Further, the practice of giving tobacco 
as an incentive should be stopped. In addition, fostering 
healthy lifestyle for patients with mental illness should be 
part of their management.
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